WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2016> 32> 9

Volume: 32 Issue: 9

1. A new understanding of etiological treatment in patients with severe viral hepatitis Page:1637—1643
2. Current status of liver failure treatment Page:1668—1672
3. Disease assessment and prognosis of liver failure Page:1673—1677
4. Definition, pathophysiology, and clinical management of acute-on-chronic liver failure Page:1684—1687
5. Advances in diagnosis and treatment of patients with acute-on-chronic liver failure complicated by acute kidney injury Page:1688—1693
6. Diagnosis and treatment of invasive fungal diseases in patients with severe liver diseases Page:1694—1698
7. Mechanism of action of direct-acting antiviral agents in treatment of chronic hepatitis C Page:1699—1705
8. Advances in Roussel Uclaf Causality Assessment Method for diagnosis of drug-induced liver injury and its comparison with structured expert opinion process Page:1706—1713
9. Efficacy of telbivudine combined with adefovir dipivoxil and pegylated interferon combined with entecavir as antiviral therapy for chronic hepatitis B: a comparative analysis Page:1714—1716
10. Clinical features of chronic HBV/HCV infection complicated by mild hepatic steatosis Page:1717—1720
11. Association of programmed cell death-1 gene polymorphisms with chronic hepatitis C virus infection and antiviral effect Page:1721—1724
12. Efficacy comparative of different laboratory test reagents for hepatitis C virus antibody Page:1725—1728
13. Effect of prohibitin on hepatitis C virus replication Page:1729—1733
14. Effect of entecavir combined with Fuzheng Huayu capsules on inflammatory factors and fibrosis markers in patients with compensated chronic hepatitis B-related cirrhosis Page:1734—1738
15. Value of indocyanine green test in evaluating liver reserve function in patients with hepatitis B cirrhosis Page:1739—1742
16. Clinical effect of laparoscopic splenectomy combined with esophagogastric devascularization in treatment of liver cirrhosis with portal hypertension Page:1743—1746
17. Elemene combined with transcatheter arterial chemoembolization in treatment of primary liver cancer: a meta-analysis Page:1747—1752
18. Value of endoscopic ultrasound and magnetic resonance cholangiopancreatography in diagnosis of obstructive jaundice Page:1753—1755
19. Clinical experience in treatment of complex intrahepatic bile duct stones by regular hepatectomy Page:1756—1759
20. Operation skills of endoscopic retrograde cholangiopancreatography in pancreaticobiliary patients with periampullary duodenal diverticula Page:1760—1762
21. Diagnosis and treatment of hypertriglyceridemic pancreatitis in pregnancy Page:1763—1765
22. Decompensated liver disease complicated by acute stroke caused by multiple factors: a clinical analysis of 15 cases Page:1770—1773. (in Chinese)
23. The role of fluoxetine in antiviral therapy for chronic hepatitis C Page:1794—1796
24. Research advances in indicators for early diagnosis of liver cirrhosis patients with renal impairment Page:1797—1800
25. Research advances in integrated traditional Chinese and Western medicine diagnosis and treatment of minimal hepatic encephalopathy Page:1801—1805
26. Current research status of mechanisms of the development and progression of liver fibrosis Page:1806—1809
27. The role of MAPK signaling pathway in development/progression and treatment of liver cancer Page:1810—1813
28. Role of uric acid in the development and progression of nonalcoholic fatty liver disease Page:1814—1818
29. Research advances in diagnosis and treatment of IgG4-associated autoimmune hepatitis Page:1819—1821
30. Research progress in biomarkers of drug-induced liver injury Page:1822—1826
31. Research progress in the role of autophagy in liver regeneration Page:1827—1830

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.